secwatch.observer — SEC 8-K summary
======================================

Issuer:     Invivyd, Inc. (IVVD)
CIK:        0001832038
Form:       8-K
Filed at:   2024-09-03T23:59:59+00:00
Accession:  0000950170-24-102552
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Invivyd announces PEMGARDA neutralizing activity against dominant variants KP.3.1.1 and LB.1
--------------------------------------------------------------------------------

- New in vitro data show PEMGARDA neutralizes KP.3.1.1 (42.2% of US cases) and LB.1 variants.
- Pemivibart epitope intact across 99.59% of viral sequences since Omicron BA.1.
- Data submitted to FDA for timely updates to PEMGARDA Fact Sheet.
- Pipeline candidate VYD2311 also shows potent neutralization against contemporary variants.
- Company notes 33 variants tested over two years; addresses preliminary non-peer-reviewed reports questioning activity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832038/000095017024102552/0000950170-24-102552-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832038/000095017024102552/ivvd-20240903.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-102552

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer